| Update of EULAR recommendations for the treatment of systemic sclerosis O Kowal-Bielecka, J Fransen, J Avouac, M Becker, A Kulak, Y Allanore, ... Annals of the rheumatic diseases 76 (8), 1327-1339, 2017 | 1129 | 2017 |
| EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) O Kowal-Bielecka, R Landewé, J Avouac, S Chwiesko, I Miniati, L Czirjak, ... Annals of the rheumatic diseases 68 (5), 620-628, 2009 | 892 | 2009 |
| Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review J Avouac, L Gossec, M Dougados Annals of the rheumatic diseases 65 (7), 845-851, 2006 | 750 | 2006 |
| International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis J Braun, T Pham, J Sieper, J Davis, SJ Van der Linden, M Dougados, ... Annals of the rheumatic diseases 62 (9), 817-824, 2003 | 628 | 2003 |
| Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 550 | 2017 |
| Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group J Avouac, J Fransen, UA Walker, V Riccieri, V Smith, C Muller, I Miniati, ... Annals of the rheumatic diseases 70 (3), 476-481, 2011 | 522 | 2011 |
| Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies M Elhai, C Meune, J Avouac, A Kahan, Y Allanore Rheumatology 51 (6), 1017-1026, 2012 | 509 | 2012 |
| Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies J Avouac, P Airò, C Meune, L Beretta, P Dieude, P Caramaschi, K Tiev, ... The Journal of rheumatology 37 (11), 2290-2298, 2010 | 382 | 2010 |
| Osteoarthritis of the knee and hip and activity: a systematic international review and synthesis (OASIS) É Vignon, JP Valat, M Rossignol, B Avouac, S Rozenberg, P Thoumie, ... Joint bone spine 73 (4), 442-455, 2006 | 373 | 2006 |
| High N‐terminal pro–brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary … Y Allanore, D Borderie, J Avouac, D Zerkak, C Meune, E Hachulla, ... Arthritis & Rheumatism 58 (1), 284-291, 2008 | 317 | 2008 |
| Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials J Avouac, L Gossec, M Dougados Osteoarthritis and cartilage 15 (8), 957-965, 2007 | 257 | 2007 |
| Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis Y Allanore, M Saad, P Dieudé, J Avouac, JHW Distler, P Amouyel, ... PLoS genetics 7 (7), e1002091, 2011 | 256 | 2011 |
| COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study J Avouac, E Drumez, E Hachulla, R Seror, S Georgin-Lavialle, ... The Lancet Rheumatology 3 (6), e419-e426, 2021 | 254 | 2021 |
| Cardiac involvement in systemic sclerosis assessed by tissue‐doppler echocardiography during routine care: A controlled study of 100 consecutive patients C Meune, J Avouac, K Wahbi, L Cabanes, J Wipff, L Mouthon, L Guillevin, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 254 | 2008 |
| Radiological hand involvement in systemic sclerosis J Avouac, H Guerini, J Wipff, N Assous, A Chevrot, A Kahan, Y Allanore Annals of the rheumatic diseases 65 (8), 1088-1092, 2006 | 244 | 2006 |
| Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR … J Avouac, U Walker, A Tyndall, A Kahan, M Matucci-Cerinic, Y Allanore The Journal of rheumatology 37 (7), 1488-1501, 2010 | 229 | 2010 |
| Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study M Elhai, M Meunier, M Matucci-Cerinic, B Maurer, G Riemekasten, ... Annals of the rheumatic diseases 72 (7), 1217-1220, 2013 | 223* | 2013 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 215 | 2021 |
| Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis P Dieudé, M Guedj, J Wipff, J Avouac, I Fajardy, E Diot, B Granel, J Sibilia, ... Arthritis & Rheumatism 60 (1), 225-233, 2009 | 214 | 2009 |
| Systemic sclerosis–associated Sjögren's syndrome and relationship to the limited cutaneous subtype: Results of a prospective study of sicca syndrome in 133 consecutive patients J Avouac, C Sordet, C Depinay, M Ardizonne, MC Vacher‐Lavenu, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 207 | 2006 |
